Brain aging has been associated with aberrant DNA methylation patterns, and changes in the levels of DNA methylation and associated markers have been observed in the brains of Alzheimer's disease (AD) patients. DNA hydroxymethylation, however, has been sparsely investigated in aging and AD. We have previously reported robust decreases in 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in the hippocampus of AD patients compared to non-demented controls. In the present study, we investigated 3-and 9-month-old APPswe/PS1ΔE9 transgenic and wild-type mice for possible age-related alterations in 5-mC and 5-hmC levels in three hippocampal sub-regions using quantitative immunohistochemistry. While age-related increases in levels of both 5-mC and 5-hmC were found in wild-type mice, APPswe/PS1ΔE9 mice showed decreased levels of 5-mC at 9 months of age and no age-related changes in 5-hmC throughout the hippocampus. Altogether, these findings suggest that aberrant amyloid processing impact on the balance between DNA methylation and hydroxymethylation in the hippocampus during aging in mice.
Introduction
Alzheimer's disease (AD) is the most common form of dementia and its neuropathology is associated with altered gene expression, in a hippocampal subregion-specific manner [1, 2] .
Mutations in the genes encoding amyloid precursor protein (APP) and presenilin (PS) 1 have been identified in autosomal dominant cases of AD and are known to affect brain function by altering APP processing during aging, producing toxic amyloid beta (Aβ) protein species [3, 4] .
Accumulating evidence suggests that epigenetic regulation of gene expression is critically involved in the pathophysiology of AD [5, 6] . Altered global levels of the DNA methylation marker 5-methylcytosine (5-mC) and changes in gene-specific methylation profiles have been observed in post-mortem brain material of AD patients, in peripheral lymphocytes of AD patients and also in animal and cell culture models of AD neuropathology [7] [8] [9] [10] [11] [12] [13] [14] . Further implication of epigenetic dysregulation in AD is supported by studies showing that treatment with HDAC inhibitors (HDACi), drugs that target the epigenetic machinery, improve behavioral outcomes in transgenic mouse models of AD [15, 16] .
The oxidized form of 5-mC, 5-hydroxymethylcytosine (5-hmC) , has also been identified as an epigenetic regulator, that is particularly abundant in the brain [17, 18] .
Additionally, oxidation of 5-mC is thought to be the initial step of an active DNA demethylation pathway [19, 20] . To date, still little is known about the role of DNA hydroxymethylation in AD [21] . Studies on the mouse hippocampus and cerebellum reported dynamic changes of 5-hmC during neurodevelopment and aging, such as an age-associated increase of hydroxymethylation of genes related to
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amyloid processing [22, 23] . Interestingly, a genetic association between AD and one of the enzymes that catalyze the 5-mC to 5-hmC conversion, ten-eleven translocation (TET) 1, has been reported [24] , suggesting that the conversion from 5-mC to 5-hmC might be particularly important in AD. Furthermore, we have reported a robust reduction of the DNA methylation marker 5-mC and the DNA methylation marker 5-hmC in the hippocampus of AD patients compared to matched controls, as well as an AD-associated decrease in 5-hmC in the hippocampus of a monozygotic twin pair discordant for AD [25] . Recently, the first epigenome-wide analyses of 5-hmC in relation to AD was published, identifying numerous sites with altered hydroxymethylation [26] .
Aging is the most important risk factor for AD and age-related changes in epigenetic mechanisms in AD-vulnerable brain regions may thus be involved in setting the stage for the development of AD [27] [28] [29] . We have previously shown in large cohorts of wildtype (WT) mice that aging is associated with increased levels of 5-mC, as well as increased levels of 5-hmC in the hippocampus and cerebellum [30] [31] [32] . However, there is no conclusive evidence on whether age-related aberrations in APP and Aβ processing impact on the balance between 5mC and 5hmC in the brain. As such, it remains unknown whether the reports of global epigenetic changes in the AD brain are closely associated with aberrant amyloid processing.
Based on the postulated misbalance between DNA methylation and DNA hydroxymethylation in the pathophysiology of AD [33] and our findings in the hippocampus of AD patients and controls [25] , the aim of the current study was to investigate age- 
Materials and methods

Animals
The present study used 11 male WT C57Bl6J 
Experimental Design
Mice were sacrificed at ages of 3 and 9 months for immunohistochemical analysis. Thus, 4
experimental groups were generated based on age and genotype: 1) 3-month-old-WT mice (n = 5), 2) 9-month-old WT mice (n = 6), 3)
3-month-old APPswe/PS1ΔE9 mice (n = 4), and 4) 9-month-old APPswe/PS1ΔE9 mice (n = 5).
Tissue processing
The mice were anaesthetized and transcardially perfused with tyrode solution and fixative solution (4% paraformaldehyde, 0.9% NaCl, 1% acetic acid). Subsequently, the brains were removed and stored in a 1% sodium azide TBS solution (at 4°C). They were then embedded in 10% gelatin and cut serially in 50 μm-thick freefloating sagittal sections using a vibratome (VT 1200S, Leica, Wetzlar, Germany), yielding 10 sub-series of every 10th section. These were stored again in 1% sodium azide TBS solution at 4°C until further histological processing.
Immunohistochemical detection of 5-mC and 5-hmC
For each immunohistochemical procedure, a series of sections was stained using standard immunohistochemical protocols as previously described [30, 31, 38] . [30, 31, 38] . For statistical analyses the raw data derived from each image (intensity and surface area) were averaged for each animal.
Surface area measurements might be affected by volume changes and could be corrected for that [38] . However, in the present study no significant hippocampal volume changes were detected (data not shown) and thus corrections for volumes were not performed.
While the present analysis focused on semiquantitative analysis of global 5-mC and 5-hmC distribution, previously published work from our group has shown quantitative validation of immunohistochemical findings using dot-blots [39] . 
Hippocampal Aβ plaque load IR
Analysis of Hippocampal Aβ plaque load densities
All measurements were performed using a modified BX50 bright field microscope Figure 1 ).
Statistical Analysis
All data are presented as mean and standard 
Results
Qualitative analysis of 5-mC and 5-hmC IR
5-mC intensity
GLM revealed a main effect of genotype in the DG (p < 0.001, F=22.2) and CA1-2 (p = 0.008, F=8.9) regions, and a main effect of age in the DG (p = 0.02, F=6.7; Figure 4A -C). Furthermore, statistically significant age x genotype interactions were observed in all hippocampal subregions (p = 0.001, F=17.3 for DG, p = 0.002, F=14.2 for CA3, and p = 0.004, F=11.1 for CA1-2; Figure 4A -C). Pairwise Bonferroni post-hoc comparisons showed that age was associated with a significant increase in the intensity of 5-mC IR in the DG (+8.6%, p = 0.001) and the CA3 (+6.5 %, p = 0.044) regions of WT mice.
Moreover, Bonferroni post-hoc comparisons revealed a decrease of 5-mC IR intensity in the 9-month-old APPswe/PS1ΔE9 mice compared to 9-month-old WT mice in all hippocampal subregions (-11.3%, p < 0.001 for DG; -9.1%, p = 0.004 for CA3; and -10.8%, p = 0.001 for CA1-2). Thus, age was associated with significantly higher levels of 5-mC IR in WT mice, whereas the APPswe/PS1ΔE9 genotype with lower levels of 5-mC IR in 9-month-old mice.
5-mC surface area
GLM for surface area measurements of 5-mC IR showed a significant age x genotype interaction in the DG (p = 0.048, F=4.6) ( Figure   4D ), but not in CA3 (p = 0.079) or CA1-2 (p = 0.104). Pairwise post-hoc comparisons using the Bonferroni correction showed that the observed changes were not specific for any individual experimental groups.
5-hmC intensity
GLM revealed non-significant effects for the main effect of age in the DG (p = 0.053) and the CA3 (p = 0.099) subregions, and no effect in the CA1-2 region (p = 0.149). Stratified analyses per genotype showed an increase of mean intensity of 5-hmC IR associated with aging from 3-to 9-month-old mice in all hippocampal subregions (p = 0.022, F=7.6 for DG, p = 0.016, F=8.64 for CA3, and p = 0.044, F=5.5 for CA1-2) in the WT mice, but not in the APPswe/PS1ΔE9 mice (p = 0.565 for DG, p = 0.688 for CA3, and p = 0.726 for CA1-2) ( Figure 5A -C).
5-hmC surface area
GLM revealed non-significant trends for increased 5-hmC surface area IR by age in the DG (p = 0.074) and the CA3 (p = 0.054) subregions, and no effect in CA1-2 (p =0.249; Figure 5D -F). Note that an increase in 5-mC IR is observed from 3 to 9 months in WT mice, while a loss of 5-mC IR is observed in from 3 to 9 months in APPswe/PS1ΔE9 mice in all three hippocampal subregions. The photomicrographs were taken with a 40x objective. Scale bar = 50 μm.
5-mC and 5-hmC correlation
Correlation analyses between 5-mC and 5-hmC IR revealed non significant positive correlations between 5-mC and 5-hmC IR in the DG (r p = 0.542, p = 0.085) and the CA3 (r p = 0.576, p = 0.064) regions of WT mice, and no effects in the CA1-2 (r p = 0.211, p = 0.534). No correlations between 5-mC and 5-hmC IR were observed in the APPswe/PS1ΔE9 transgenic mice ( Figure   6A -F).
Hippocampal Aβ plaque load densities
Amyloid plaque analysis demonstrated an agedependent deposition from 3-to 9-month old mice ( Supplementary Figure 1 ).
Discussion
Qualitative and quantitative assessment of the various hippocampal subregions revealed that aging in WT mice was associated with increased levels of 5-mC and 5-hmC. APPswe/ PS1ΔE9 mice showed, however, lower levels of 5-mC IR at 9 months of age and no significant alterations in 5-hmC levels. Altogether, these findings indicate that mutations in APP and/ or PS1 impact on the balance between DNA methylation and hydroxymethylation in the aging hippocampus.
Age-related increase of hippocampal 5-mC and 5-hmC IR in WT mice
In the present study, 5-mC IR was increased in 9-month-old compared to 3-month-old WT mice. As the anti-5-mC antibody detects CpGrich loci with higher sensitivity, the observed increase of 5-mC IR likely reflects increased methylation of CpG islands [31] . These findings are in agreement with studies reporting that aging is associated with increases in global DNA methylation in brains of rodents [40, 41] , as well as hypermethylation of CpG islands and loss of methylation of loci outside CpG islands [27, 42, 43] . Our current findings of increased 5-mC IR from 3-to 9-month-old WT mice are in accordance with our earlier findings of age-associated increases in levels of 5-mC [31] and DNA methylation-associated markers, like Dnmt3a and HDAC2 in C57Bl6 mice [38, 44] . Similar to the findings on 5-mC IR in WT mice, 5-hmC IR in hippocampal subregions showed an age-related increase from 3-to 9-month-old in WT mice. 5-hmC has recently gained increased attention as it was described to be particularly abundant in the brain [45, 46] . A number of studies have shown that 5-hmC, which is an oxidized form of 5-mC, has a different role in the regulation of gene expression when compared to 5-mC [47] [48] [49] [50] .
Our finding of an age-associated increase of 5-hmC IR in WT mice parallels a report showing increases in 5-hmC in the aging mouse cerebellum [22] . Interestingly, the increases in DNA hydroxymethylation in that study were particularly pronounced in genes related to neurodegeneration, including those encoding presenilins and secretases. The current findings are also in agreement with our previous observations of increasing hippocampal 5-hmC IR with age in mice [30] . We have furthermore observed correlations between 5-mC and 5-hmC in WT mice, but considering the significant main effects of age, it is difficult to ascertain whether the correlations observed in these cases are independent of age.
Disturbed age-related alterations of 5-mC and 5-hmC in APPswe/PS1ΔE9 mice
Noticeable differences were observed in the temporal patterns of age-related changes in 5-mC IR in WT as compared with APPswe/ PS1ΔΕ9 mice: 5-mC IR increased with aging from 3 to 9 months of age in WT mice, while aging from 3 to 9 months of age in APPswe/ PS1ΔΕ9 mice was associated with lower levels of 5-mC IR. A similar, but less pronounced, Pooled data from the 4 groups of 3-month-old (white bars) and 9-month-old wild-type (WT) and APPswe/PS1ΔE9 mice (black bars) are represented separately for the dentate gyrus (DG; A, D), cornu ammonis (CA) 3 (B, E), and CA1-2 (C, F). Statistically significant effects from the univariate analysis of variance including age and genotype are displayed in the upper right corner of the graphs. In case of a significant age x genotype interaction no main effects are shown. Statistically significant differences between the age and genotype groups, as determined through Bonferroni-corrected post-hoc comparisons, are also indicated in the graphs. AU, arbitrary units; *p < 0.05; **p < 0.01; ***p < 0.001. Figure 5 . 5-hydroxymethylcytosine (5-hmC) intensity and surface area. Mean and standard error of the mean intensity value measurements of 5-hmC immunoreactivity (IR; A-F). Pooled data from the 4 groups of 3-month-old (white bars) and 9-month-old (black bars) wild-type (WT) and APPswe/PS1ΔE9 mice are represented separately for the dentate gyrus (DG; A, D), cornu ammonis (CA) 3 (B, E), and CA1-2 (C, F). No statistically significant effects of age or genotype were found with a univariate analysis of variance, however a stratified analysis per genotype showed age-related increases of 5-hmC intensity in the WT mice, as shown in the graphs. AU, arbitrary units; *p < 0.05.
5-mC Intensity
(AU) [11, 55, 56] , while dietary supplementation with the methyl-donor S-adenosylmethionine was found to ameliorate these alterations [57] .
A recent study on epigenetic changes with age in various animal models of AD did not find an age-related decrease in hippocampal 5-mC or 5-hmC in APP/PS1dE9 mice, but did find an age-related decrease in hippocampal 5-mC in J20 mice, expressing human mutant APP [58] . An important distinction with the present study, however, is that we compared 
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5-hmC IR # r p = 0,576 (n.s.)
A B C # r p = 0,542 (n.s.) r p = 0,211 (n.s.)
r p = -0,118 (n.s.) r p = -0,078 (n.s.) r p = 0,113 (n.s.)
3xTg-AD mice, which carry mutations of APP, PS1, and Tau [60] . This discrepancy could be explained by methodological differences, such as the different brain areas examined (hippocampus vs. cortex), tissue processing or alternatively directly linked to the differences in the mutations and neuropathology characteristics between the 3xTg-AD and the APP/PS1ΔE9 mice [61, 62] . More specifically the 3xTg-AD mice develop tau pathology in addition to amyloid pathology. Therefore, it could be speculated that the presence of tau pathology induces alterations in 5-hmC that
were not captured in our study. To support this notion studies in AD patients and transgenic AD drosophila have specifically linked 5-hmC changes with tau-mediated neurotoxicity [63] . Clearly, the interrelations between aging, amyloid processing, and DNA (hydroxy) methylation are complex and further work in this area is needed.
Overall, the present findings can be linked to our previous observations of decreased 5-mC and 5-hmC in the hippocampus of AD patients and controls [25] and suggest that the presence of amyloid pathology is closely related to robust changes in global DNA methylation. In line with our present findings, various reports have shown alterations in DNA methylation in certain brain regions as well as in lymphocytes of AD patients when compared to controls (for review see: [5] It is important to mention that many of the current techniques used for the detection of DNA methylation either cannot detect 5-hmC or cannot discriminate it reliably from 5-mC [69] [70] [71] . Thus, the importance of 5-hmC might be underestimated in current epigenetics research on aging and AD [33] . Interestingly our group has shown an increase of 5-hmC in a specific layer of the sub-ventricular zone of patients with AD which is associated with neurogenesis and proliferation in that area [39] .
Limitations, future prospects and conclusions
The current study design involved WT and double transgenic APPswe/PS1ΔE9 mice.
As such, it cannot be explained whether In conclusion, the present findings reveal differential age-associated changes of DNA methylation and hydroxymethylation in the hippocampus of WT and transgenic APPswe/ PS1ΔE9 mice and suggest that an altered DNA methylation/hydroxymethylation balance is involved in the pathophysiology of AD.
Supplementary Figure 1 . Hippocampal plaque load in 3-and 9-month-old APPswe/PS1ΔΕ9 mice. Mean and standard error of the mean of hippocampal plaque loads (percentage of area covered by plaques compared to total area) in the whole hippocampus (A) and the three hippocampal subregions (dentate gyrus [DG], cornu ammonis [CA] 3, and CA1-2; B, C, and D respectively) of transgenic APPswe/PS1ΔΕ9 mice. Note that a clear increase in plaque load is observed from 3-to 9-month-old mice. These measurements were performed to validate the age-dependent hippocampal amyloid-β plaque deposition in the mice used. 
